PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24592408-0 2014 Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats. Pioglitazone 11-23 insulin Felis catus 27-34 24592408-3 2014 OBJECTIVE: To evaluate the effects of pioglitazone in obese cats, which are predisposed to insulin resistance, to assess its potential for future use in feline diabetes mellitus. Pioglitazone 38-50 insulin Felis catus 91-98 24592408-9 2014 CONCLUSIONS AND CLINICAL IMPORTANCE: Results of this study support a positive effect of pioglitazone on insulin sensitivity and lipid metabolism in obese cats, and suggest that further evaluation of the drug in cats with diabetes mellitus or other metabolic disorders might be warranted. Pioglitazone 88-100 insulin Felis catus 104-111 22612529-3 2012 The purpose of this study was to investigate the pharmacokinetics of pioglitazone in lean and obese cats, to provide a foundation for assessment of its effects on insulin sensitivity and lipid metabolism. Pioglitazone 69-81 insulin Felis catus 163-170